Last reviewed · How we verify
Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia
A randomized, open-label, multicenter study to compare the efficacy and safety of teriflunomide plus high-dose dexamethasone compared to high-dose dexamethasone monotherapy for the first-line treatment of adults with newly diagnosed primary immune thrombocytopenia (ITP).
Details
| Lead sponsor | Peking University People's Hospital |
|---|---|
| Phase | PHASE2 |
| Status | WITHDRAWN |
| Start date | Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Immune Thrombocytopenia
Interventions
- Teriflunomide
- Dexamethasone
Countries
China